Overview

Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare two combinations of drugs, minocycline and creatine or celecoxib and creatine, in a phase II trial designed to determine which combination is more effective for ALS.
Phase:
Phase 2
Details
Lead Sponsor:
Columbia University
Collaborators:
ALS Association
Pfizer
Treatments:
Celecoxib
Minocycline